Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Solifenacin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Solifenacin 5mg tablets
0704020ABAAAAAA
|
Solifenacin | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 293,365 |
|
Solifenacin 10mg tablets
0704020ABAAABAB
|
Solifenacin | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 221,873 |
|
Vesicare 5mg tablets
0704020ABBBAAAA
|
Vesicare | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 4,083 |
|
Vesicare 10mg tablets
0704020ABBBABAB
|
Vesicare | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,987 |
|
Solifenacin 1mg/ml oral suspension sugar free
0704020ABAAAFAF
|
Solifenacin | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,171 |
|
Solifenacin 5mg/5ml oral solution sugar free
0704020ABAAAGAG
|
Solifenacin | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 519 |
|
Vesicare 1mg/ml oral suspension
0704020ABBBACAF
|
Vesicare | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 124 |
|
Solifenacin 10mg/5ml oral liquid
0704020ABAAAEAE
|
Solifenacin | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 19 |
|
Giraxine 10mg tablets
0704020ABBCAAAB
|
Giraxine | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Giraxine 5mg tablets
0704020ABBCABAA
|
Giraxine | Solifenacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.